Algert Global LLC Mirati Therapeutics, Inc. Transaction History

Algert Global LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $2.37 Million - $3.51 Million	-56,341 Reduced 75.84%	17,945 $1.05 Million
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $21,406 - $34,919	770 Added 1.05%	74,286 $3.24 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $371,849 - $509,351	10,292 Added 16.28%	73,516 $2.66 Million
Q1 2023 May 12, 2023	BUY	$36.54 - $54.26 $1.25 Million - $1.85 Million	34,079 Added 116.93%	63,224 $2.35 Million
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $393,715 - $940,834	9,540 Added 48.66%	29,145 $1.32 Million
Q3 2022 Nov 15, 2022	BUY	$59.5 - $86.7 $464,397 - $676,693	7,805 Added 66.14%	19,605 $1.37 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $16,329 - $36,992	417 Added 3.66%	11,800 $792,000
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $661,756 - $1.32 Million	8,728 Added 328.74%	11,383 $936,000
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $228,377 - $329,201	-1,730 Reduced 39.45%	2,655 $389,000
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $216,825 - $291,195	1,641 Added 59.8%	4,385 $776,000
Q2 2021 Aug 13, 2021	BUY	$144.0 - $179.73 $53,424 - $66,679	371 Added 15.63%	2,744 $443,000
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $377,117 - $525,880	2,373 New	2,373 $406,000
Q2 2020 Aug 12, 2020	SELL	$72.01 - $120.39 $516,599 - $863,677	-7,174 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$69.78 - $116.21 $500,601 - $833,690	7,174 New	7,174 $551,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.